Mar 1, 2008
By:
Laura Bush
The cause of the heparin crisis is still unknown. We do know, however, that the FDA is severely underfunded.
|
Feb 12, 2008
By:
Laura Bush
The US FDA has requested nearly $2.4 billion for its fiscal 2009 budget, a 5.7% increase over the budget that FDA received for the current fiscal year.
|
Feb 12, 2008
By:
Laura Bush
A public database of extractables and leachables data would save time, effort, and costs during drug development, agreed participants at the CMC Strategy Forum on Extractables and Leachables on January 27.
|
In our increasingly global industry; foreign manufacturing inspections are more important than ever.
Feb 1, 2008
By:
Laura Bush
In our increasingly global industry; foreign manufacturing inspections are more important than ever.
|
|
BioPharm International's second annual salary survey confirms that the biopharmaceutical industry is a great place to work
Jan 1, 2008
By:
Laura Bush
Our second annual salary survey assesses not only how much people earn, but also how they feel about it.
|
Jan 1, 2008
By:
Laura Bush
The number one source of job satisfaction? A sense of accomplishment from a job well done.
|
Dec 1, 2007
By:
Laura Bush
Many companies acknowledged that Western regulatory standards are tougher than those in China.
|
Nov 1, 2007
By:
Laura Bush
The challenge is not in coming up with a list of activities to discard, but in finding a feasible way to stop doing them.
|
Oct 10, 2007
By:
Laura Bush
The upcoming Quality by Design (QbD) pilot program for biotech filings will focus on comparability protocols, Helen Winkle, director of the Office of Pharmaceutical Science at the FDA's Center for Drug Evaluation and Research, said on September 20, 2007.
|
|
